MOG35-55 i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways

European Journal of Immunology

Volumn 39, Issue 3, 2009, Pages 789-799

  Jiang, Zhilong ^a   Li, Hongmei ^a   Fitzgerald, Denise C ^a   Zhang, Guang Xian ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cytokine; EAE MS; Intracellular signaling; MOG i.v.

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 27; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN [35-55]; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; GLYCOPROTEIN; INTERLEUKIN 23; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT; STAT1 PROTEIN, MOUSE; STAT4 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SPLEEN CELL; TH17 CELL; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; HELPER CELL; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GLYCOPROTEINS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; JANUS KINASES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PEPTIDE FRAGMENTS; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 64049118358     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838427     Document Type: Article

References (56)

1. Correale, J. and Tenembaum, S. N., Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis. Mult. Scler. 2006. 12: 412-420.
2. Maier, J., Kincaid, C., Pagenstecher, A. and Campbell, I. L., Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis. Am. J. Pathol. 2002. 160: 271-288.
3. Miljkovic, D., Momcilovic, M., Stojanovic, I., Stosic-Grujicic, S., Ramic, Z. and Mostarica-Stojkovic, M., Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro. J. Neurosci. Res. 2007. 85: 3598-3606.
4. Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C., Cannella, B., Raine, C. S., Goverman, J. and Lenardo, M. J., T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994. 263: 1139-1143.
5. Whitacre, C. C., Gienapp, I. E., Orosz, C. G. and Bitar, D. M., Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 1991. 147: 2155-2163.
6. Zhang, G. X., Xu, H., Kishi, M., Calida, D. and Rostami, A., The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 2002. 168: 2501-2507.
7. Smith, C. E. and Miller, S. D., Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. J. Autoimmun. 2006. 27: 218-231.
8. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L., Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994. 265: 1237-1240.
9. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. and Weiner, H. L., Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA. 1992. 89: 421-425.
10. Weishaupt, A., Jander, S., Bruck, W., Kuhlmann, T., Stienekemeier, M., Hartung, T., Toyka, K. V., Stoll, G. and Gold, R., Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J. Immunol. 2000. 165: 7157-7163.
11. Bettelli, E., Dastrange, M. and Oukka, M., Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 2005. 102: 5138-5143.
12. Aarvak, T., Chabaud, M., Miossec, P. and Natvig, J. B., IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 1999. 162: 1246-1251.
13. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
14. McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T. and Cua, D. J., TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007. 8: 1390-1397.
15. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A. and Goverman, J. M., Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008. 14: 337-342.
16. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535-1541.
17. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J. and Ghilardi, N., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006. 7: 929-936.
18. Fitzgerald, D. C., Ciric, B., Touil, T., Harle, H., Grammatikopolou, J., Das Sarma, J., Gran, B. et al., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 3268-3275.
19. Jee, Y., Kim, G., Tanuma, N. and Matsumoto, Y., STAT expression and localization in the central nervous system during autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. 2001. 114: 40-47.
20. Nishikomori, R., Usui, T., Wu, C. Y., Morinobu, A., O'Shea, J. J. and Strober, W., Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J. Immunol. 2002. 169: 4388-4398.
21. Subramaniam, S. V., Cooper, R. S. and Adunyah, S. E., Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochem. Biophys. Res. Commun. 1999. 262: 14-19.
22. Greve, B., Weissert, R., Hamdi, N., Bettelli, E., Sobel, R. A., Coyle, A., Kuchroo, V. K. et al., I kappa B kinase 2/beta deficiency controls expansion of autoreactive T cells and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 179-185.
23. Boyton, R. J., Davies, S., Marden, C., Fantino, C., Reynolds, C., Portugal, K., Dewchand, H. et al., Stat4-null non-obese diabetic mice: Protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. Int. Immunol. 2005. 17: 1157-1165.
24. Chitnis, T., Najafian, N., Benou, C., Salama, A. D., Grusby, M. J., Sayegh, M. H. and Khoury, S. J., Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 2001. 108: 739-747.
25. Burkhart, C., Liu, G. Y., Anderton, S. M., Metzler, B. and Wraith, D. C., Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10. Int. Immunol. 1999. 11: 1625-1634.
26. Ratts, R. B., Arredondo, L. R., Bittner, P., Perrin, P. J., Lovett-Racke, A. E. and Racke, M. K., The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: I.v. antigen administration. Int. Immunol. 1999. 11: 1889-1896.
27. Hilliard, B. A., Kamoun, M., Ventura, E. and Rostami, A., Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: Role of regulatory spleen cells. Exp. Mol. Pathol. 2000. 68: 29-37.
28. Eagar, T. N., Karandikar, N. J., Bluestone, J. A. and Miller, S. D., The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur. J. Immunol. 2002. 32: 972-981.
29. Sakaguchi, S.,Wing, K. and Miyara, M., Regulatory T cells - a brief history and perspective. Eur. J. Immunol. 2007. 37:S116-S123.
30. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006. 441: 231-234.
31. Vanden Eijnden, S., Goriely, S., De Wit, D., Willems, F. and Goldman, M., IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol. 2005. 35: 469-475.
32. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F. and Pelletier, J. P., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998. 160: 3513-3521.
33. Hofstetter, H. H., Toyka, K. V., Tary-Lehmann, M. and Lehmann, P. V., Kinetics and organ distribution of IL-17-producing CD4 cells in proteo-lipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J. Immunol. 2007. 178: 1372-1378.
34. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007. 13: 1173-1175.
35. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M. and Fugger, L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008. 172: 146-155.
36. Bettelli, E., Oukka, M. and Kuchroo, V. K., T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007. 8: 345-350.
37. Tarrant, T. K., Silver, P. B., Wahlsten, J. L., Rizzo, L. V., Chan, C. C., Wiggert, B. and Caspi, R. R., Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 1999. 189: 219-230.
38. Zhang, G. X., Yu, S., Calida, D., Zhao, Z., Gran, B., Kamoun, M. and Rostami, A., Loss of the surface antigen 3G11 characterizes a distinct population of anergic/regulatory T cells in experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 3366-3373.
39. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
40. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
41. Suryani, S., Sutton, I., An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J. Neuroimmunol. 2007. 183: 96-103.
42. Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Induction of IL-171T cell trafficking and development by IFN-gamma: Mechanism and pathological relevance in psoriasis. J. Immunol. 2008. 181: 4733-4741
43. O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C.W., Leech, M. D., Wraith, D. C., Anderton, S. M. Cutting Edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 3750-3754.
44. Giannoukakis, N., Bonham, C. A., Qian, S., Chen, Z., Peng, L., Harnaha, J., Li, W. et al., Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol. Ther. 2000. 1: 430-437.
45. Anderson, P., Sundstedt, A., Li, L., O'Neill, E. J., Li, S., Wraith, D. C. and Wang, P., Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int. Immunol. 2003. 15: 1309-1317.
46. - mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 5788-5796.
47. Muthian, G., Raikwar, H. P., Rajasingh, J. and Bright, J. J., 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J. Neurosci. Res. 2006. 83: 1299-1309.
48. Slavin, A. J., Maron, R. and Weiner, H. L., Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int. Immunol. 2001. 13: 825-833.
49. Mekala, D. J., Alli, R. S. and Geiger, T. L., IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+T lymphocytes. Proc. Natl. Acad. Sci. USA 2005. 102: 11817-11822.
50. Fitzgerald, D. C., Zhang, G. X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007. 8: 1372-1379.
51. Wang, J., Wang, G., Sun, B., Li, H., Mu, L., Wang, Q., Li, G., Interleukin -27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J. Autoimmun. 2008. 30: 222-229.
52. Guo, B., Chang, E. Y., Cheng, G., The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 2008. 118: 1680-1690.
53. Lee, H. K. and Iwasaki, A., Innate control of adaptive immunity: dendritic cells and beyond. Semin. Immunol. 2007. 19: 48-55.
54. Unanue, E. R., Antigen-presenting function of the macrophage. Annu. Rev. Immunol. 1984. 2: 395-428.
55. Smith, W., Feldmann, M. and Londei, M., Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production. Eur. J. Immunol. 1998. 28: 2498-2507.
56. Benson, J. M. K. A., Campbell, Z., Guan, I. E., Gienapp, S. S., Stuckman, T., Forsthuber., Whitacre, C. C., 2000. T-cell activation and receptor down-modulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 2000. 106:1031-1038.